MYCN and neuroblastoma: Neuroblastomas in general, and especially those harbouring MYCN amplification37, exist in a highly immunosuppressive tumour microenvironment such that future iterations of PC-CARs may require additional engineering to enable T cells to navigate to the pMHC target.